Press Release Mar 25 2023
Filed with NSE · · 1 page · English
Summary by 6ix AI
Zydus Lifesciences Limited has issued a press release regarding a recent inspection by the USFDA at its manufacturing facility in Ahmedabad. The inspection, which took place over several days, included a Pre-Approval Inspection and a GMP Audit, resulting in three observations. The company confirmed that there were no Data Integrity related observations and is currently addressing the noted issues.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Mar 24 2023
- Press Release Mar 21 2023
- Press Release Mar 15 2023
- Press Release Mar 09 2023
- Press Release Mar 07 2023
Later from Zydus Lifesciences
- Press Release Mar 28 2023
- Press Release Apr 06 2023
- Press Release Apr 10 2023
- Press Release Apr 11 2023
- Press Release Apr 15 2023
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences